Zobrazeno 1 - 3
of 3
pro vyhledávání: '"F N U Deepika"'
Autor:
Elliot Ballato, F N U Deepika, Mia Prado, Vittoria Russo, Virginia Fuenmayor, Dennis T Villareal, Clifford Qualls, Reina Armamento-Villareal
Publikováno v:
Journal of the Endocrine Society. 6:A167-A168
Background An emerging field of research concerns the deleterious effects of type 2 diabetes mellitus (T2DM) on bone. Our group has previously reported a hemoglobin A1c (A1c) threshold of 7% where bone impairment occurs as reflected by reduction in b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a10d910390e23debef3e981d21cd6eb
https://doi.org/10.1210/jendso/bvac150.344
https://doi.org/10.1210/jendso/bvac150.344
Publikováno v:
Journal of the Endocrine Society. 6:A220-A221
Introduction Denosumab inhibits receptor activator of nuclear factor k-B ligand and is approved to treat giant cell tumor of bone (GCTB). Rebound hypercalcemia is a rare complication of denosumab withdrawal in pediatrics which is not reported in adul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f45b41158511905e3d19a892b817860
https://doi.org/10.1210/jendso/bvac150.452
https://doi.org/10.1210/jendso/bvac150.452
Autor:
Elliot Ballato, F. N. U. Deepika, Vittoria Russo, Alcibiades Fleires-Gutiérrez, Georgia Colleluori, Virginia Fuenmayor, Rui Chen, Dennis T. Villareal, Clifford Qualls, Reina Armamento-Villareal
Publikováno v:
Calcif Tissue Int
INTRODUCTION: Type 2 diabetes mellitus (T2DM) is associated with normal or slightly elevated bone mineral density (BMD) but paradoxically increased fracture risk. Although multiple mechanisms have been proposed to explain this observation, one thing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98a1272e3f08e17c689a07835c8a2764
https://pubmed.ncbi.nlm.nih.gov/35665818
https://pubmed.ncbi.nlm.nih.gov/35665818